BR0316609A - Sinomenina e compostos de sinomenina, sìntese e uso - Google Patents

Sinomenina e compostos de sinomenina, sìntese e uso

Info

Publication number
BR0316609A
BR0316609A BR0316609-0A BR0316609A BR0316609A BR 0316609 A BR0316609 A BR 0316609A BR 0316609 A BR0316609 A BR 0316609A BR 0316609 A BR0316609 A BR 0316609A
Authority
BR
Brazil
Prior art keywords
synomenin
compounds
synthesis
group
synomenine
Prior art date
Application number
BR0316609-0A
Other languages
English (en)
Inventor
Guo-Wei Qin
Xi-Can Tang
Rui Wang
Tian-Xi Zhou
Pierre Lestage
Daniel Henri Caignard
Pierre Renard
Original Assignee
Shanghai Inst Materia Medica
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Materia Medica, Servier Lab filed Critical Shanghai Inst Materia Medica
Publication of BR0316609A publication Critical patent/BR0316609A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

"SINOMENINA E COMPOSTOS DE SINOMENINA, SìNTESE E USO". A invenção refere-se a sinomenina e a seus compostos e também a compostos da fórmula (I), em que R~ 1~ representa um grupo alquila; R~ 2~ representa um átomo de hidrogênio ou um grupo alquilcarbonila, um grupo haloalquilcarbonila ou um arilcarbonila; Y representa um grupo (IV); R~ 3~, R~ 4~, R<39>~ 4~, R<39>~ 5~ e R~ 6~ são como definidos na descrição; e X representa um átomo de halogênio. Medicamentos.
BR0316609-0A 2002-11-28 2003-11-26 Sinomenina e compostos de sinomenina, sìntese e uso BR0316609A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB021538190A CN1328280C (zh) 2002-11-28 2002-11-28 汉防己碱和汉防己碱化合物,合成和应用
PCT/EP2003/014841 WO2004048340A1 (en) 2002-11-28 2003-11-26 Sinomenine and sinomenine compounds, synthesis and use

Publications (1)

Publication Number Publication Date
BR0316609A true BR0316609A (pt) 2005-10-11

Family

ID=32331921

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316609-0A BR0316609A (pt) 2002-11-28 2003-11-26 Sinomenina e compostos de sinomenina, sìntese e uso

Country Status (15)

Country Link
US (1) US20060009480A1 (pt)
EP (1) EP1565444A1 (pt)
JP (1) JP2006509755A (pt)
KR (1) KR100706462B1 (pt)
CN (2) CN1328280C (pt)
AU (1) AU2003290119A1 (pt)
BR (1) BR0316609A (pt)
CA (1) CA2507067A1 (pt)
EA (1) EA200500862A1 (pt)
MA (1) MA27573A1 (pt)
MX (1) MXPA05005687A (pt)
NO (1) NO20053139L (pt)
PL (1) PL377695A1 (pt)
WO (1) WO2004048340A1 (pt)
ZA (1) ZA200504055B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1298718C (zh) * 2005-03-18 2007-02-07 中国科学院上海有机化学研究所 C环连接有吡嗪环的青藤碱衍生物、合成方法及其用途
CN1298720C (zh) * 2005-03-18 2007-02-07 中国科学院上海有机化学研究所 C环连接有五元杂环的青藤碱衍生物和合成方法
CN100455571C (zh) * 2005-12-09 2009-01-28 湖南正清制药集团股份有限公司 青藤碱盐化合物及其制备方法
CN101578101B (zh) * 2005-12-15 2012-05-23 自然医学公司 青藤碱衍生物的制备和应用
US7932264B2 (en) 2005-12-15 2011-04-26 Naturemed Group Corporation Sinomenine derivatives and preparation and uses thereof
CN100408578C (zh) * 2006-03-15 2008-08-06 南京大学 一类17-酰基青藤碱衍生物及其制备方法
CN1876634A (zh) * 2006-06-19 2006-12-13 湖南正清制药集团股份有限公司 一种青藤碱结构改造化合物及其制备方法
CN101092397B (zh) * 2006-06-19 2011-01-19 湖南正清制药集团股份有限公司 一种青藤碱结构改造化合物及其制备方法
US20070290378A1 (en) * 2006-06-20 2007-12-20 International Business Machines Corporation Novel reworkable underfills for ceramic mcm c4 protection
CN100396686C (zh) * 2006-08-03 2008-06-25 西安皓天生物工程技术有限责任公司 一种汉防己甲素和汉防己乙素的制备方法
CN102093373A (zh) * 2007-06-19 2011-06-15 湖南正清制药集团股份有限公司 一种青藤碱结构改造化合物及其制备方法
JP5579076B2 (ja) * 2007-12-17 2014-08-27 マリンクロッド エルエルシー シノメニン誘導体およびそれらの合成のためのプロセス
WO2010096790A1 (en) * 2009-02-23 2010-08-26 Mallinckrodt Inc. (+)-morphinananium n-oxides and processes for their production
EP2340832A1 (en) * 2009-12-23 2011-07-06 Universität Innsbruck Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases
CN101798285B (zh) * 2010-02-10 2012-05-23 中国科学院上海有机化学研究所 一种青藤碱衍生物、合成方法及其用途
CN101899004A (zh) * 2010-06-24 2010-12-01 江苏大学 青藤碱衍生物、制备方法及其医药用途
CN101948430A (zh) * 2010-09-01 2011-01-19 南京大学 青藤碱衍生物及其制备方法和应用
CN102532024B (zh) * 2011-12-28 2016-08-03 赵爱国 青藤碱衍生物
CN104274817B (zh) * 2014-09-25 2016-06-15 中山大学 Wrw三肽在制备治疗阿尔茨海默症药物中的用途
CN104306954B (zh) * 2014-09-25 2016-08-24 中山大学 Wry三肽在制备治疗阿尔茨海默症药物中的用途
CN104258372B (zh) * 2014-09-25 2017-01-25 中山大学 Rgd三肽在制备治疗阿尔茨海默症药物中的用途
CN104258371B (zh) * 2014-09-25 2016-06-15 中山大学 Www三肽在制备治疗阿尔茨海默症药物中的用途
AU2017217535A1 (en) 2016-02-10 2018-09-27 James Gray PILAAR Enhanced inflatable sound attenuation system
CN107648179A (zh) * 2017-09-21 2018-02-02 浙江中医药大学 一种治疗类风湿性关节炎的新型皮肤给药制剂及其制备方法
CN108704640B (zh) * 2018-06-13 2021-03-30 绍兴市梓昂新材料有限公司 一种多孔氧化铂催化剂的制备方法
CN110433132B (zh) * 2019-08-19 2023-06-30 中国人民解放军军事科学院军事医学研究院 治疗创伤后应激障碍的粉防己碱鼻用制剂
CN113880764B (zh) * 2020-07-01 2023-04-18 北京师范大学 青藤碱衍生物及其制备方法与应用
CN114831990A (zh) * 2022-03-22 2022-08-02 台州恩泽医疗中心(集团) 青藤碱在制备治疗帕金森病药物组合物中的应用
CN115260098A (zh) * 2022-06-09 2022-11-01 澳门科技大学 Abcb5抑制剂在制备多耐药性类风湿性关节炎治疗药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912114A (en) * 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
WO1995003307A1 (fr) * 1993-07-19 1995-02-02 Toray Industries, Inc. Agent de protection de cellules cerebrales
US6372756B1 (en) * 1998-02-20 2002-04-16 Avmax, Inc. Epimorphian compound and its use

Also Published As

Publication number Publication date
KR100706462B1 (ko) 2007-04-10
CN1504469A (zh) 2004-06-16
AU2003290119A1 (en) 2004-06-18
NO20053139L (no) 2005-06-27
CN1720232A (zh) 2006-01-11
JP2006509755A (ja) 2006-03-23
KR20050071712A (ko) 2005-07-07
PL377695A1 (pl) 2006-02-06
MA27573A1 (fr) 2005-10-03
ZA200504055B (en) 2006-08-30
CA2507067A1 (en) 2004-06-10
US20060009480A1 (en) 2006-01-12
WO2004048340A8 (en) 2005-07-07
MXPA05005687A (es) 2005-08-16
WO2004048340A1 (en) 2004-06-10
EP1565444A1 (en) 2005-08-24
CN1328280C (zh) 2007-07-25
EA200500862A1 (ru) 2005-12-29

Similar Documents

Publication Publication Date Title
BR0316609A (pt) Sinomenina e compostos de sinomenina, sìntese e uso
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
BR0307960A (pt) N-aminoacetil-pirrolidina-2-carbonitrilas e seu uso como inibidores de ddp-iv
SE9904652D0 (sv) Novel Compounds
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
DE60211223D1 (de) Piperidinderivate als Kalium-Kanal Blockers
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
BR0208741A (pt) Derivados de piperidina
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
BRPI0409164A (pt) pirazóis substituìdos
BR0314275A (pt) Derivados de hidantoina e seu uso como inibidores de tace
BR9916111A (pt) Derivados de fenilglicina
BR0214666A (pt) Derivados de acetileno tendo atividade antagonìstica de mglur5
BR0208192A (pt) Derivados espirotricìclicos e seu uso como inibidores da fosfodiesterase-7.
BR0111981A (pt) herbicidas de piridina substituìda
HN2002000300A (es) Nuevos derivados de piperazina
BR0114252A (pt) Derivados de nitrosodifenilamina
ATE260275T1 (de) Substituierte thien-3-yl- sulfonylamino(thio)carbonyl-triazolin(thi)one
SV2004001555A (es) Difenilazetidinonas cationicamente sustituidas, procesos para su preparacion, medicamentos que contienen estos compuestos y sus usos
BR0208053A (pt) Sìntese de moléculas isoflavonas diméricas, composições contendo as mesmas e seus usos como agentes terapêuticos
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
BRPI0601766A (pt) composições contendo aminas e seu uso
PE20020144A1 (es) Derivados de pleuromutilinas como agentes antibacterianos
DE60031886D1 (de) Purinderivate
BRPI0411209A (pt) uso de derivados isoindolinona como inseticidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A, E 7A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.